Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 7/20 | 0.63 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.63 |
| ▸ | MGLL | Q99685 | 9/20 | 0.58 |
| ▸ | FAAH | O00519 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.58 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | XBP1 | P17861 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22353278 | 0.91 | PTGS1 (0.65) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL29044909 | 0.89 | MGLL (0.54) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL16405262 | 0.89 | MGLL (0.54) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL17972723 | 0.87 | PTGS1 (0.50) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL2222522 | 0.85 | PTGS1 (0.89) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL20621983 | 0.83 | MGLL (0.70) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL29064048 | 0.83 | PTGS1 (0.64) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL16274103 | 0.83 | MGLL (0.65) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL13543586 | 0.83 | MGLL (0.70) | PTGS1PTGS2MGLLFAAHALDH1A1 | |
| SCHEMBL17570363 | 0.83 | PTGS1 (0.48) | PTGS1PTGS2MGLLFAAHALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227799-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-07-20 | — | — | US | disclosed |
| US-20230212535-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-07-06 | — | — | US | disclosed |
| US-20180037874-A9 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2018-02-08 | — | — | US | disclosed |
| US-9797009-B2 | Enzyme construct | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2017-10-24 | — | — | US | disclosed |
| US-9636418-B2 | Potent and selective inhibitors of NAV1.7 | AMGEN INC. (US) | 2017-05-02 | — | — | US | disclosed |
| US-20160257942-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2016-09-08 | — | — | US | disclosed |
| US-20150218629-A1 | ENZYME CONSTRUCT | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2015-08-06 | — | — | US | disclosed |
| US-20150197796-A1 | SSB METHOD | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2015-07-16 | — | — | US | disclosed |
| US-20150191709-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2015-07-09 | — | — | US | disclosed |
| US-20150023988-A1 | POTENT AND SELECTIVE INHIBITORS OF NAV1.7 | AMGEN INC. (US) | 2015-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150023988-A1 | POTENT AND SELECTIVE INHIBITORS OF NAV1.7 | SCN7A, SCN9A, SCN1A | PTGS1 2922/4885PTGS2 3218/4885MGLL 4337/4885 |
| US-20150218629-A1 | ENZYME CONSTRUCT | DCLRE1B, DNA2, WRN | PTGS1 3233/4885PTGS2 3120/4885MGLL 2286/4885 |
| US-20230227799-A1 | MODIFIED HELICASES | DDX21, DDX5, DDX17 | PTGS1 3466/4885PTGS2 3570/4885MGLL 3782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.